An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies

ABSTRACT:

SUBMITTER: Mazein A 

PROVIDER: S-EPMC12371706 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature